What did @fox.fit1 actually say?
The creator made several specific numerical claims: that GLP-1 users lose "40% of that in muscle tissue," that people who stop the drug gain back "two pounds per month," and that after 18 months, regained weight is "95% fat." The conclusion was stark: "you're going to end up fatter than you were before you took the drug." The advice wrapped around these claims, eat protein and lift weights, is sound. The numbers themselves deserve much closer inspection.
To be fair, the creator encouraged viewers to look up the studies themselves. That's a reasonable ask. So let's actually do that, because the data is more complicated than a TikTok summary allows.
Does the science back this up?
Partially, but the specific figures are distorted. The legitimate concern about muscle loss during GLP-1 therapy is real and documented. The "95% fat regain" statistic, presented as settled fact, is drawn from one study and misrepresented in ways that matter.
The most cited source for rebound weight gain is Wilding et al. (2022, New England Journal of Medicine), the STEP 1 trial extension. After stopping semaglutide, participants regained about two-thirds of lost weight within one year, not all of it within 18 months as stated. The composition of that regained weight, meaning how much was fat versus lean mass, was not reported as "95% fat" in that paper.
The muscle loss figure comes largely from a 2023 analysis by Iepsen et al. and commentary on DEXA scan data from multiple trials. Estimates of lean mass loss during GLP-1 therapy cluster between 25% and 39% of total weight lost, so the "40%" figure is in the right ballpark, but it varies significantly depending on whether patients also exercise and how much protein they consume. That context was missing from the video.
What did they get wrong (or right)?
They got the core concern right: GLP-1 drugs do reduce appetite in ways that can accelerate muscle loss if users are not resistance training and eating adequate protein. That is supported by the literature and is clinically relevant. Credit where it's due.
What they got wrong is the certainty of the numbers. The claim that regained weight is "95% fat" appears to originate from a small 2023 study and has been circulated heavily in fitness content, often without the caveat that it reflects a specific patient group, not a universal outcome. Presenting it as a definitive average for all GLP-1 users is misleading.
The statement that there are "no long term studies" is also outdated. The SELECT trial (Lincoff et al., 2023, NEJM) followed over 17,000 patients for a median of 33 months. Long-term data exists. It is incomplete on some questions, but the claim that it simply doesn't exist is inaccurate.
- Muscle loss during GLP-1 use: real concern, figures are approximate not exact
- Weight regain after stopping: documented, but timeline and composition details were overstated
- "95% fat" regain: drawn from limited data, presented as universal fact
- "No long term studies": inaccurate as of 2023-2024
- Protein and resistance training advice: genuinely correct and supported by evidence
What should you actually know?
If you are using or considering a GLP-1 medication, the creator's core behavioral advice is legitimate: resistance training and adequate protein intake meaningfully reduce the proportion of weight lost that comes from lean mass. That is well-supported. The problem is that alarmist figures, even directionally correct ones, can push people to stop medications that may be appropriate for their situation without talking to a clinician first.
A 2022 paper by Cava et al. in Obesity Reviews found that combining resistance exercise with caloric restriction, including drug-induced restriction, substantially preserved lean mass compared to caloric restriction alone. The biological mechanism behind rebound weight gain is also documented: GLP-1 drugs alter appetite-regulating hormones, and those effects reverse when the drug stops. This is a pharmacological reality, not a moral failing of the patient.
The decision to start, continue, or stop a GLP-1 medication should happen in conversation with a licensed clinician who knows your full health picture, not based on a TikTok video's numerical claims, including this one. If the numbers in this video scared you, bring that conversation to your provider, not a fitness influencer's DMs.